(HealthDay)—Certain patients on active surveillance for prostate cancer may be eligible for less intensive surveillance, according to a study published in the January issue of The Journal of Urology.
Dec 23, 2016
0
0
(HealthDay)—Magnetic resonance imaging (MRI) and MRI-targeted biopsies have a role in the diagnosis and treatment of patients with a prior negative prostate biopsy, according to a review published in the December issue ...
Dec 16, 2016
0
1
(HealthDay)—For patients with prostate cancer (PCa), methylation of the paired-like homeodomain transcription factor 2 (PITX2) gene is feasible for individualized risk assessment in prostate core biopsies before surgery, ...
Dec 13, 2016
0
0
Prostate-specific antigen (PSA) and other biomarkers are essential tools for diagnosing and monitoring prostate cancer. However, biomarkers to selectively identify patients with high risk of recurrence, those who might benefit ...
Dec 8, 2016
0
1
If, when, and how men with negative biopsies for prostate cancer should continue to be monitored are questions facing patients and health care providers in view of concerns and criticisms about over detection, overtreatment, ...
Dec 6, 2016
0
1
(HealthDay)—In a consensus statement from the American Urological Association and Society of Abdominal Radiology, published in the December issue of The Journal of Urology, guidelines are presented for prostate magnetic ...
Nov 18, 2016
0
6
In a study published online by JAMA Surgery, Jim C. Hu, M.D., M.P.H., Joshua A. Halpern, M.D., M.S., of Weill Cornell Medicine, New York, and colleagues examined effects on practice patterns in prostate cancer diagnosis and ...
Nov 2, 2016
0
0
When it comes to prostate cancer biopsies, risk and reality don't always match up, according to research published online today in the Journal of Clinical Oncology.
Oct 31, 2016
0
18
New research confirms that an innovative procedure combining MRI and ultrasound to create a 3-D image of the prostate can more accurately locate suspicious areas and help diagnose whether it's prostate cancer.
Sep 14, 2016
0
10
For three years, Andrew Harder wondered if he had prostate cancer. In 2009, he had routine blood work that revealed an elevated prostate-specific antigen level. When PSA is above 4 nanograms per milliliter of blood, it can ...
Jul 21, 2016
0
38
